Knowledge translation for nephrologists: Strategies for improving the identification of patients with proteinuria

Journal of Nephrology

Volumn 25, Issue 6, 2012, Pages 933-943

  Hemmelgarn, Brenda R ^a   Manns, Braden J ^a   Straus, Sharon ^b   Naugler, Christopher ^c   Holroyd Leduc, Jayna ^a   Braun, Ted C ^d   Levin, Adeera ^e   Klarenbach, Scott ^f   Lee, Patrick F ^a   Hafez, Kevin ^a   Schwartz, Daniel ^e   Jindal, Kailash ^f   Ervin, Kathy ^d   Bello, Aminu ^f   Turin, Tanvir Chowdhury ^a   McBrien, Kerry ^a   Elliott, Meghan ^a   Tonelli, Marcello ^f  

^a UNIVERSITY OF CALGARY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d ALBERTA HEALTH SERVICES   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Clinical practice guidelines; Implementation; Knowledge translation; Proteinuria

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; KNOWLEDGE MANAGEMENT; MEDICAL DECISION MAKING; MORTALITY; NEPHROLOGIST; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; PROTEINURIA;

CLINICAL COMPETENCE; COOPERATIVE BEHAVIOR; DECISION SUPPORT TECHNIQUES; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; INTERDISCIPLINARY COMMUNICATION; NEPHROLOGY; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84870615450     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000226     Document Type: Article

References (18)

1. Straus SE, Tetroe J, Graham I. Defining knowledge translation. CMAJ. 2009;181(3-4):165-168.
2. Kastner M, Sawka A, Thorpe K, et al. Evaluation of a clinical decision support tool for osteoporosis disease management: protocol for an interrupted time series design. Implement Sci. 2011;6(1):77.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2) (Suppl 1):S1-S266.
4. Matsushita K, van der Velde M, Astor BC, et al. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-2081.
5. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Alberta Kidney Disease Network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423-429.
6. Tonelli M, Muntner P, Lloyd A, et al. Alberta Kidney Disease Network. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med. 2011;154(1):12-21.
7. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010; 375(9722):1296-1309.
8. Giatras I, Lau J, Levey AS. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med. 1997;127(5):337-345.
9. Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ. 2004;329(7470):828.
10. Manns BTM, Culleton B, Faris P, et al. A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease. Clin J Am Soc Nephrol. 2012;7(4):1-9.
11. Levin A. The need for optimal and coordinated management of CKD. Kidney Int Suppl. 2005;68(99):S7-S10.
12. Nissenson AR, Pereira BJ, Collins AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis. 2001;37(6):1177-1183.
13. Stevens LA, Fares G, Fleming J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005;16(8):2439-2448.
14. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001;37(3):484-489.
15. Shlipak MG, Fried LF, Crump C, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62(3):997-1004.
16. Majumdar SR, McAlister FA, Furberg CD. From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol. 2004;43(10):1738-1742.
17. Cochrane Effective Practice and Organisation of Care Group. Information specific to EPOC reviews. Available at: http://epoc.cochrane.org/information-specific-epoc-reviews. Accessed April 10, 2012.
18. Hemmelgarn BR, Clement F, Manns BJ, et al. Overview of the Alberta Kidney Disease Network. BMC Nephrol. 2009;10(1):30.